453 related articles for article (PubMed ID: 10582709)
1. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
2. Ability of breast cancer cell lines to stimulate bone resorbing activity of mature osteoclasts correlates with an anti-apoptotic effect mediated by macrophage colony stimulating factor.
Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Apoptosis; 2006 Nov; 11(11):1909-21. PubMed ID: 16927019
[TBL] [Abstract][Full Text] [Related]
3. Cellular mechanisms of bone resorption in breast carcinoma.
Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
5. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Gorny G; Shaw A; Oursler MJ
Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts.
Gallet M; Sévenet N; Dupont C; Brazier M; Kamel S
Biochem Biophys Res Commun; 2004 Jun; 319(2):690-6. PubMed ID: 15178461
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
[TBL] [Abstract][Full Text] [Related]
9. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro.
Pfeilschifter J; Chenu C; Bird A; Mundy GR; Roodman GD
J Bone Miner Res; 1989 Feb; 4(1):113-8. PubMed ID: 2785743
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta.
Oursler MJ
J Bone Miner Res; 1994 Apr; 9(4):443-52. PubMed ID: 8030431
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
Hussein O; Tiedemann K; Komarova SV
Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment.
Pilkington MF; Sims SM; Dixon SJ
J Bone Miner Res; 2001 Jul; 16(7):1237-47. PubMed ID: 11450699
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
[TBL] [Abstract][Full Text] [Related]
19. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
20. Effects of human lymphocyte-conditioned medium on MG-63 human osteosarcoma cell function.
Stock JL; Coderre JA; DeVito WJ; Baker S
Cytokine; 1998 Aug; 10(8):603-12. PubMed ID: 9722933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
